制造单细菌微凝与气体剪切策略,用于IBD治疗中的精密益生菌输送
Jialin Wu1, Lili Wu1, Ruiying Liu2
1Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 511436, P. R. China.
Research (Washington, D.C.)
|November 27, 2025
概括
新的气体剪切技术创造了单个细菌的微凝,改善了益生菌的输送和肠道健康和炎症性肠道疾病治疗的疗效.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 材料科学 材料科学 材料科学
背景情况:
- 人的肠道微生物群在健康中起着至关重要的作用,影响免疫调节和身体平衡.
- 肠道微生物群的破坏与各种疾病有关,这突显了需要有效干预的需要.
- 益生菌显示治疗潜力,但在胃肠道输送和生存方面面临重大挑战.
研究的目的:
- 开发一种精确有效的方法来封装单个细菌以提高益生菌的传递.
- 为了克服传统封装技术的局限性,例如目标不佳,颗粒大小控制和胃肠道的生存.
- 评估单细菌微凝在治疗炎症性肠病中的治疗效果.
主要方法:
- 利用气体剪切技术制造单个细菌微凝,封装单个细菌细胞.
- 证明能够覆盖多种微生物物种,包括细菌和真菌,具有良好的生物相容性和机械完整性.
- 在炎症性肠病模型中研究了封装Escherichia coli Nissle 1917的疗效.
主要成果:
- 气体剪切方法成功地产生了具有增强生存和准能力的单细菌微凝.
- 与未封装细菌相比,封装益生菌在治疗炎症性肠病方面显著提高了治疗效果.
- 微凝系统表现出良好的生物相容性和对封装微生物的机械支持.
结论:
- 气体剪切封装是制造单细菌微凝的一个有希望的策略.
- 这种新的方法提高了益生菌的生存率和治疗效率,特别是在诸如炎症性肠道疾病等胃肠道疾病中.
- 这项技术有可能在生物医学和营养药物应用中开发先进的益生菌疗法.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
Bioreactor Controls-II
In aerobic fermentations, oxygen is vital for microbial growth and metabolite production. Since air comprises only about 20% oxygen and the gas is poorly soluble in water—just 9 ppm at 20°C—supplying sufficient oxygen becomes a critical challenge, especially in high-demand processes like yeast growth or citric acid production. Even a fully saturated broth may offer only a few seconds of oxygen availability.To address this, sterile or scrubbed air is introduced into the fermentor via a sparger...


